Antiretroviral therapy coverage for PMTCT in Haiti

Haiti: Antiretroviral therapy coverage for PMTCT was 60.0% in 2024. ◆ Volatile

Latest (2024)
60.0%
Change on year
down 10.4%
World rank
61st
of 84 countries
All-time high
100.0%
in 2013
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Haiti, 2000–2024

0204060801002000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 1 % of pregnant women living with HIV2005: 10 % of pregnant women living with HIV2006: 23 % of pregnant women living with HIV2007: 44 % of pregnant women living with HIV2008: 46 % of pregnant women living with HIV2009: 56 % of pregnant women living with HIV2010: 46 % of pregnant women living with HIV2011: 76 % of pregnant women living with HIV2012: 99 % of pregnant women living with HIV2013: 100 % of pregnant women living with HIV2014: 94 % of pregnant women living with HIV2015: 91 % of pregnant women living with HIV2016: 85 % of pregnant women living with HIV2017: 92 % of pregnant women living with HIV2018: 98 % of pregnant women living with HIV2019: 100 % of pregnant women living with HIV2020: 84 % of pregnant women living with HIV2021: 78 % of pregnant women living with HIV2022: 70 % of pregnant women living with HIV2023: 67 % of pregnant women living with HIV2024: 60 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Haiti is 60.0%, measured in 2024.

The figure is down 10.4% on the previous year and down 36.2% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Haiti peaked at 100.0% in 2013 and was at its lowest, 0.0%, in 2000.

Haiti ranks 61st of 84 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Haiti, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Haiti, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 10.0% +900.0%
2006 23.0% +130.0%
2007 44.0% +91.3%
2008 46.0% +4.5%
2009 56.0% +21.7%
2010 46.0% -17.9%
2011 76.0% +65.2%
2012 99.0% +30.3%
2013 100.0% +1.0%
2014 94.0% -6.0%
2015 91.0% -3.2%
2016 85.0% -6.6%
2017 92.0% +8.2%
2018 98.0% +6.5%
2019 100.0% +2.0%
2020 84.0% -16.0%
2021 78.0% -7.1%
2022 70.0% -10.3%
2023 67.0% -4.3%
2024 60.0% -10.4%

Haiti compared with similar countries

  • Haiti's 60.0% is below the median for lower middle income countries, which is 83.5%, 72% of the median. (32 countries reporting)
  • Haiti's 60.0% is below the median for Latin America & Caribbean, which is 68.0%, 88% of the median. (15 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Haiti changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +900.0% 1.0% 10.0%
2006 +130.0% 10.0% 23.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 18.0% 0.0% 56.0% 10
2010s 88.1% 46.0% 100.0% 10
2020s 71.8% 60.0% 84.0% 5

Countries ranked near Haiti

  1. 58 Burundi 65.0% compare
  2. 58 Nepal 65.0% compare
  3. 60 Niger 63.0% compare
  4. 62 Cameroon 59.0% compare
  5. 63 Fiji 57.0% compare
  6. 64 Netherlands 55.0% compare

See the full ranking of 99 places →

More health data for Haiti

All data for Haiti →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Haiti?
Antiretroviral therapy coverage for pmtct in Haiti was 60.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Haiti?
The highest recorded value was 100.0% in 2013.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Haiti?
The lowest recorded value was 0.0% in 2000.
How does Haiti rank for antiretroviral therapy coverage for pmtct?
Haiti ranks 61st out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Haiti?
Over the last ten years it is down 36.2%. The long-run trend across the full record is volatile.
Where does this Haiti data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Haiti. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/haiti/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/haiti/">Antiretroviral therapy coverage for PMTCT in Haiti</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).